SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001773
Filing Date
2023-08-11
Accepted
2023-08-11 16:05:44
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q seel-20230630x10q.htm   iXBRL 10-Q 1919245
2 EX-31.1 seel-20230630xex31d1.htm EX-31.1 16342
3 EX-31.2 seel-20230630xex31d2.htm EX-31.2 15173
4 EX-32.1 seel-20230630xex32d1.htm EX-32.1 6843
5 EX-32.2 seel-20230630xex32d2.htm EX-32.2 6816
  Complete submission text file 0001410578-23-001773.txt   7311941

Data Files

Seq Description Document Type Size
6 EX-101.SCH seel-20230630.xsd EX-101.SCH 54887
7 EX-101.CAL seel-20230630_cal.xml EX-101.CAL 40949
8 EX-101.DEF seel-20230630_def.xml EX-101.DEF 222920
9 EX-101.LAB seel-20230630_lab.xml EX-101.LAB 486684
10 EX-101.PRE seel-20230630_pre.xml EX-101.PRE 362598
57 EXTRACTED XBRL INSTANCE DOCUMENT seel-20230630x10q_htm.xml XML 1134423
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 231164020
SIC: 2834 Pharmaceutical Preparations